Research interests

DK: Behandling af kræftsygdomme i hoved-hals området. Nye systemiske behandlinger og strålebehandlingsteknikker.

UK: Treatment of cancer diseases in the head and neck area. New systematic treatments and radiation treatment techniques.

Workgroups

• WP7 - Late effects and Patient Reported Outcomes

Publications

• Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts Int J Cancer . 2022 Apr 15;150(8):1329-1340 2022
• Cecilie Holländer-Mieritz, Ivan R Vogelius, Claus A Kristensen, Allan Green, Judith L Rindum, Helle Pappot Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study JMIR Res Protoc. 2021 May 13;10(5):e26096 2021
• Kristian Hastoft Jensen, Ivan Richter Vogelius, Mogens Bernsdorf, Anita Gothelf, Claus Andrup Kristensen, Christian Maare , Elo Andersen, Lena Specht, Jeppe Friborg Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma Radiother Oncol. 2022 Jun;171:1-6 2022
• Holländer-Mieritz C, Johansen J, Taarnhøj GA, Johansen C, Vogelius IR, Kristensen CA, Pappot H Systematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trial Acta Oncol. 2020 May;59(5):603-607 2020
• Jensen KH, Vogelius I, Kristensen CA, Andersen E, Overgaard J, Eriksen JG, Primdahl H, Johansen J, Farhadi M, Andersen M, Friborg J Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database. Clin Oncol (R Coll Radiol) . 2020 Jul 19;S0936-6555(20)30286-7. 2020
• Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Eriksen JG, Overgaard J NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncol. 2019 Oct;58(10):1410-1415. 2019
• Holländer-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot H Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires. Acta Oncol. 2019 May;58(5):603-609. 2019
• Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial. Acta Oncol. 2018 Sep;57(9):1159-1164 2018